Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6698964 | 7367825 | F | 6698964-9 | 20100420 | 20100427 | EXP | B0643299A | GLAXOSMITHKLINE | 18 | YR | F | Y | 20100427 | MD | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6698964 | 1013578723 | SS | ATARAX | 1 | INTRAVENOUS | 25MG THREE TIMES PER DAY | |||||
6698964 | 1013578724 | PS | ZOVIRAX | 1 | ORAL | 200MG PER DAY | 018603 | ||||
6698964 | 1013578725 | SS | SANDIMMUNE | 1 | INTRAVENOUS | 120MG PER DAY | |||||
6698964 | 1013578726 | SS | MEROPEN | 2 | INTRAVENOUS | 2G TWICE PER DAY | |||||
6698964 | 1013578727 | SS | AMPHOTERICIN B | 1 | INTRAVENOUS | 50MG PER DAY |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6698964 | 1013578723 | PAIN |
6698964 | 1013578724 | ANTIVIRAL PROPHYLAXIS |
6698964 | 1013578725 | GRAFT VERSUS HOST DISEASE |
6698964 | 1013578726 | INFECTION |
6698964 | 1013578727 | INFECTION |
Outcome of event
Event ID | OUTC COD |
---|---|
6698964 | HO |
6698964 | OT |
Reactions reported
Event ID | PT |
---|---|
6698964 | PERSONALITY CHANGE |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6698964 | 1013578723 | 20091215 | 20100311 | 87 | DAY |
6698964 | 1013578724 | 20100126 | |||
6698964 | 1013578725 | 20091221 | 20100123 | 34 | DAY |
6698964 | 1013578726 | 20091221 | 20100224 | 66 | DAY |
6698964 | 1013578727 | 20091128 | 20100305 | 98 | DAY |